JavaScript is disabled. Please enable to continue!

Mobile search icon
Media Centre >> News >> Eurofins | Newsletter - December 2017 | Cosmetics

Eurofins | Newsletter - December 2017 | Cosmetics

Sidebar Image

Europe 

Endocrine Disruptors

 

Endocrine Disruptors are a “hot topic” nowadays.

 

These substances can affect the human health (affecting to the hormonal system) and the environment.

 

They can be found in a lot of products of daily use such as cosmetics, biocides, food contact materials, foodstuff, etc.

 

As an example, European Commission recently notified WTO (World Trade Organization) a draft proposal Commission Delegated Regulation (EU) 2017/2100 of 4 September 2017 setting out scientific criteria for the determination of endocrine-disrupting properties pursuant to Regulation (EU) No 528/2012 of the European Parliament and Council.

 

Europe  

Recent SCCS Views on Cosmetics

 

Following a list of the recent opinions of Scientific Committee on Consumer Safety (SCCS) (non-exhaustive list):

 

SCCS - Minutes of the Working Group Meeting on Cosmetic Ingredients of 26 September 2017.

SCCS - Mandate Issued for Hair Dye A165

SCCS - Mandate Issued for Zinc Pyrithione

SCCS - WG on Nanomaterials in Cosmetic Products

 

Europe 

Request for a Scientific Opinion on Hair Dye A165

 

The ingredients Hydroxypropyl p-phenylenediamine and its dihydrochloride salt (A165) are intended to be used in oxidative hair colouring products up to a maximum on-head concentration of 2%.

 

The Scientific Committee on Consumer Safety (SCCS) has been requested to give an opinion regarding the safety of use of this ingredient and its salts when used in oxidative hair colouring products up to a maximum on-head concentration of 2%.

 

Deadline for the opinion: March 2018.

 

Click here to access the mandate.


 

Europe  

Request for an Addendum to the Scientific Opinion on the Safety of Zinc Pyrithione  (ZTP)

 

ZPT is currently regulated as a preservative in rinse-off products (excluding oral hygiene products) in a concentration up to 0.5% in general and up to 1.0% in hair products (Annex V/8).

 

Furthermore, ZPT is also allowed in a concentration up to 0.1% in leave-on hair products (Annex III/101).

 

A CLH dossier was submitted in October 2016 by the Swedish Chemicals Agency ("KEMI") to ECHA to support the harmonised classification and labelling of ZPT as a CMR 1B.

 

As new studies are available and used in the CLH report for ZPT, the Scientific Committee on Consumer Safety (SCCS) has been requested to give its opinion on the safety of use of ZPT as an anti-dandruff agent in rinse-off hair care products up to 2% (compliant with the previous opinion SCCS/1512/13).

 

Deadline for the opinion: 02/2018.

 

Click here to access the mandate.

 

Canada

Update of the Cosmetic Ingredient Hotlist

 

On November 8, 2017, Health Canada proposed to update the Cosmetic Ingredient Hotlist. This proposal includes the following points:

 

Added substance

Ingredient / substance

CAS

Synonyms and Related Compounds (including but not limited to)

Restriction

Pigment Red 4

2814-77-9

Red 36, CI 12085

3%

Substances with changes in the requirements

Ingredient

CAS

Synonyms and Related Compounds (Including but not limited to)

Chloramine T and related compounds

127-65-1;
7080-50-4;
144-86-5

Chloramine T trihydrate;
N-Chloro-p-toluenesulfonamide

Nerium oleander, its extracts and glycosides

465-16-7; 84929-39-5

Oleandrin; Neriifolin; Thevetin A; Thevetin B

Restricted substances

Chemical

CAS

Conditions of Use by product type

Maximum Concentration Permitted

Methylisothiazolinone (MI)

2682-20-4

a) Not permitted in leave-on products.

 

b) Rinse-off products
Note: If MI is present in a formulation with Methylisothiazolinone /Methylchloroisothiazolinone (MI/MCI) in combination, the cumulative, total concentration of MI and MI/MCI may not exceed 0.0015%

b) 0.0015%

Methylisothiazolinone/ Methylchloroisothiazolinone (MI/MCI) in combination

26172-55-4  2682-20-4

a) Not permitted in leave-on products.

 

b) Rinse-off products.

Note: MCI is only permitted when present in combination with MI.
If MI/MCI is present in a formulation with MI alone, the cumulative, total concentration of MI/MCI and MI may not exceed 0.0015%.

b) 0.0015%

Click here for reading the official text.